Coil volume embolization ratio for preventing recanalization after portal vein embolization

被引:0
|
作者
Maruyama, Mitsunari [1 ]
Yoshizako, Takeshi [1 ]
Ando, Shinji [1 ]
Nakamura, Megumi [1 ]
Tajima, Yoshitsugu [2 ]
Kitagaki, Hajime [1 ]
机构
[1] Shimane Univ, Fac Med, Dept Radiol, Enya Cho, Izumo, Shimane, Japan
[2] Shimane Univ, Fac Med, Dept Hepatobiliary Pancreat Surg, Enya Cho, Izumo, Shimane, Japan
关键词
FUTURE REMNANT LIVER; INTRACRANIAL ANEURYSMS; COMPLICATIONS; HEPATECTOMY; REDUCTION; UTILITY; SAFETY; SPECT;
D O I
10.5152/dir.2021.20043
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE The purpose of this study was to evaluate the optimum volume embolization ratio (VER) for the prevention of recanalization after portal vein embolization (PVE) and the influence of recanalization on future liver remnant (FLR) function using technetium-99m galactosyl human serum albumin single- photon emission computed tomography (Tc-99m-GSA SPECT/CT) fusion imaging. METHODS We analyzed procedural data of 18 patients who underwent PVE from 2015 to 2018. A total of 29 portal branches were embolized (12 anterior branch, 11 posterior branch, 4 left branch, 2 right branch) with absolute ethanol and coils. Portal vein recanalization was evaluated three weeks after PVE by contrast-enhanced CT. We classified the treated portal branches as non- recanalized and recanalized. VER was compared between the groups. In addition, for each patient, we calculated and evaluated the ratio of FLR volume to total liver volume (volumetric %FLR), FLR count to total liver count on Tc-99m-GSA SPECT/ CT fusion imaging (functional % FLR), and functional- volumetric ratio (functional %FLR/ volumetric %FLR). RESULTS Twenty-six portal branches showed no recanalization (non-recanalized group, n=26, 89.7%), while three portal branches showed recanalization (recanalized group, n=3, 10.3%). The median VER was 4.94% (3.12%-11.1%) in the non-recanalized group and 3.49% (2.76%-4.32%) in the recanalized group, which was significantly different between the groups (p = 0.045, Mann-Whitney U test). The median functional-volumetric ratio was 1.16 (1.03-1.50) in non-recanalized patients (n=15, 83.3%) and 1.01 (0.96-1.13) in recanalized patients (n=3, 16.7%), and it was significantly higher in the non- recanalized patients (p = 0.021, Mann-Whitney U test). CONCLUSION The VER for preventing recanalization after PVE was approximately 5% (> 4.94%). Tc-99m-GSA SPECT/ CT fusion imaging revealed a decrease in FLR function due to recanalization after PVE.
引用
收藏
页码:366 / 371
页数:6
相关论文
共 50 条
  • [31] Combined simultaneous embolization of the portal vein and hepatic vein (double vein embolization) – a technical note about embolization sequence
    Arash Najafi
    Erik Schadde
    Christoph A. Binkert
    CVIR Endovascular, 4
  • [32] Hepatic parenchymal transection increases liver volume but not function after portal vein embolization in rabbits
    Olthof, Pim B.
    Schadde, Erik
    van Lienden, Krijn P.
    Heger, Michal
    de Bruin, Kora
    Verheij, Joanne
    Bennink, Roelof J.
    van Gulik, Thomas M.
    SURGERY, 2017, 162 (04) : 732 - 741
  • [33] Portal Vein Embolization for Hepatocellular Carcinoma
    Shindoh, Junichi
    Tzeng, Ching-Wei D.
    Vauthey, Jean-Nicolas
    LIVER CANCER, 2012, 1 (3-4) : 159 - 167
  • [34] Predictors of failure to reach a sufficient liver volume prior to hepatecomy after portal vein embolization
    Sergeant, G.
    Schadde, E.
    Ardiles, V.
    Tschuor, C.
    Slankamenac, K.
    Croome, K.
    Baumgart, J.
    Lang, H.
    Hernandez-Alejandro, R.
    De Sanibanes, E.
    Clavien, P.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 11 - 11
  • [35] Quality Improvement for Portal Vein Embolization
    Denys, Alban
    Bize, Pierre
    Demartines, Nicolas
    Deschamps, Frederic
    De Baere, Thierry
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2010, 33 (03) : 452 - 456
  • [36] Portal vein embolization: Present and future
    Piron, Lauranne
    Deshayes, Emmanuel
    Escal, Laure
    Souche, Regis
    Herrero, Astrid
    Pierredon-Foulongne, Marie-Ange
    Assenat, Eric
    Ngo le Lam
    Quenet, Francois
    Guiu, Boris
    BULLETIN DU CANCER, 2017, 104 (05) : 407 - 416
  • [37] Portal Vein Embolization in Hilar Cholangiocarcinoma
    Palavecino, Martin
    Abdalla, Eddie K.
    Madoff, David C.
    Vauthey, Jean-Nicolas
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 18 (02) : 257 - +
  • [38] Controversies in the Use of Portal Vein Embolization
    van Gulik, Thomas M.
    van den Esschert, Jacomina W.
    de Graaf, Wilmar
    van Lienden, Krijn P.
    Busch, Olivier R. C.
    Heger, Michal
    van Delden, Otto M.
    Lameris, Johan S.
    Gouma, Dirk J.
    DIGESTIVE SURGERY, 2008, 25 (06) : 436 - 444
  • [39] Preoperative portal vein embolization: is it useful?
    Takayama, T
    Makuuchi, M
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2004, 11 (01): : 17 - 20
  • [40] EMBOLIZATION OF THE INTRAHEPATIC PORTAL-VEIN
    GRABBE, E
    BUURMAN, R
    FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NUKLEARMEDIZIN, 1984, 141 (04): : 461 - 463